New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 13, 2013
07:45 EDTENDPEndo Health price target lowered to $36 from $42 at Stifel
Stifel reduced its price target on Endo Health after the FDA denied the company's Citizen Petition on OpanaER. The firm was surprised by the FDA's decision ,and thinks the company will now have to restructure, but keeps a Buy rating based on valuation.
News For ENDP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 20, 2015
08:09 EDTENDPBioSpecifics announces approval of Xiaflex in Japan
Subscribe for More Information
July 17, 2015
10:05 EDTENDPOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:38 EDTENDPLeerink puts 25% odds on Teva, Mylan deal within 12 months
Subscribe for More Information
06:43 EDTENDPEndo upgraded to Top Pick from Outperform at RBC Capital
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use